Hyperinsulinemia
27
4
6
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
93.3%
+6.7% vs benchmark
4%
1 trials in Phase 3/4
36%
5 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 14 completed trials
Clinical Trials (27)
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Glycemic Effect of Diazoxide in NAFLD
Graded Insulin Suppression Test P&F
Diazoxide Suppression Test P&F Study
Effect of Insulin Lowering on Lipogenesis
Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults
Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in Patients With Extreme Glucose Metabolism Phenotypes
Reprometabolic Syndrome Mediates Subfertility in Obesity
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Pancreatic Clamp in NAFLD
Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β
The Movie Theater Study
Effect of Alpelisib in Healthy Volunteers
Developing a Physiological Understanding of High Duration Activity
Time-restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome
Saliva Insulin Responses to a Standardized Meal Tolerance Test in Humans
A Cold Physical Treatment to Manage Insulin Resistance
Natriuretic Peptides and Metabolic Risk in Obesity
Maternal Lifestyle and Neonatal Hypoglycemia
Metformin to Treat Obesity in Children With Insulin Resistance